NASDAQ:MGTX

MeiraGTx (MGTX) Stock Price, News & Analysis

MeiraGTx logo
$8.13 -0.19 (-2.28%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$8.22 +0.09 (+1.17%)
As of 11/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About MeiraGTx Stock (NASDAQ:MGTX)

Advanced

Key Stats

Today's Range
$8.08
▼
$8.52
50-Day Range
$8.13
▼
$13.25
52-Week Range
$6.62
▼
$15.35
Volume
964,917 shs
Average Volume
648,656 shs
Market Capitalization
$794.54 million
P/E Ratio
10.16
Dividend Yield
N/A
Price Target
$24.00
Consensus Rating
Moderate Buy

Company Overview

MeiraGTx Holdings plc is a biotechnology company developing gene therapies for serious diseases with limited treatment options. Its research focuses on using adeno-associated virus (AAV) vectors to deliver genetic material to target cells, including in programs for inherited retinal diseases, neurological conditions and salivary gland dysfunction.

The company also develops manufacturing capabilities and technologies intended to support the production of gene therapies. MeiraGTx was founded in 2015 and has operations in the United States and the United Kingdom. Its chief executive officer is Alexandria Forbes, who co-founded the company.

AI Generated. May Contain Errors.

MeiraGTx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

MGTX MarketRank™: 
2.51065878146 of 5 stars

MeiraGTx scored higher than 50% of companies evaluated by MarketBeat, and ranked 474th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MeiraGTx has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    MeiraGTx has a consensus price target of $24.00, representing about 195.2% upside from its current price of $8.13.

  • Amount of Analyst Coverage

    MeiraGTx has only been the subject of 3 research reports in the past 90 days.

  • Read more about MeiraGTx's stock forecast and price target.
  • Earnings Growth

    Earnings for MeiraGTx are expected to decrease in the coming year, from $0.20 to ($2.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MeiraGTx is 10.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.29.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MeiraGTx is 10.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 31.95.

  • Price to Book Value per Share Ratio

    MeiraGTx has a P/B Ratio of 3.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.47% of the float of MeiraGTx has been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MeiraGTx has recently increased by 3.15%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    MeiraGTx does not currently pay a dividend.

  • Dividend Growth

    MeiraGTx does not have a long track record of dividend growth.

  • News Sentiment

    MeiraGTx has a news sentiment score of -0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for MeiraGTx this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for MGTX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,375,392.00 in company stock.

  • Percentage Held by Insiders

    7.40% of the stock of MeiraGTx is held by insiders.

  • Percentage Held by Institutions

    67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MeiraGTx's insider trading history.
Receive MGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MGTX Stock News Headlines

MeiraGTx (NASDAQ:MGTX) Stock: Insider Alexandria Forbes Sells 62,000 Shares
FY2026 EPS Estimates for MeiraGTx Decreased by HC Wainwright
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
MeiraGTx Announces Oral Presentation at ObesityWeek 2026
MeiraGTx (NASDAQ:MGTX) Downgraded by Wall Street Zen to Hold
See More Headlines

MGTX Stock Analysis - Frequently Asked Questions

MeiraGTx's stock was trading at $7.95 at the beginning of the year. Since then, MGTX stock has increased by 2.3% and is now trading at $8.13.

MeiraGTx Holdings PLC (NASDAQ:MGTX) announced its quarterly earnings results on Thursday, November, 12th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.50) by $0.03. The company earned $4.81 million during the quarter, compared to analysts' expectations of $6.95 million. MeiraGTx had a trailing twelve-month return on equity of 85.23% and a net margin of 19.46%.

MeiraGTx (MGTX) raised $75 million in an initial public offering on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager.

Top institutional investors of MeiraGTx include State Street Corp (1.48%), Goldman Sachs Group Inc. (1.19%), Assenagon Asset Management S.A. (0.23%) and Privium Fund Management B.V. (0.22%). Insiders that own company stock include Perceptive Advisors Llc, Alexandria Forbes, Richard Giroux and Stuart Naylor.
View institutional ownership trends
.

Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Micron Technology (MU), Novavax (NVAX) and PayPal (PYPL).

Company Calendar

Last Earnings
11/12/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:MGTX
CIK
1735438
Fax
N/A
Employees
393
Year Founded
2015

Price Target and Rating

High Price Target
$35.00
Low Price Target
$16.00
Potential Upside/Downside
+195.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.80
Trailing P/E Ratio
10.16
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$114.20 million
Net Margins
19.46%
Pretax Margin
20.19%
Return on Equity
85.23%
Return on Assets
24.12%

Debt

Debt-to-Equity Ratio
0.57
Current Ratio
4.62
Quick Ratio
4.62

Sales & Book Value

Annual Sales
$81.39 million
Price / Sales
9.76
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.20 per share
Price / Book
3.70

Miscellaneous

Outstanding Shares
97,730,000
Free Float
90,499,000
Market Cap
$794.54 million
Optionable
Optionable
Beta
1.09

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:MGTX) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners